Michael Becker to Neoplastic Stem Cells
This is a "connection" page, showing publications Michael Becker has written about Neoplastic Stem Cells.
Connection Strength
0.124
-
Selective activity of the histone deacetylase inhibitor AR-42 against leukemia stem cells: a novel potential strategy in acute myelogenous leukemia. Mol Cancer Ther. 2014 Aug; 13(8):1979-90.
Score: 0.094
-
Acquired Resistance of ER-Positive Breast Cancer to Endocrine Treatment Confers an Adaptive Sensitivity to TRAIL through Posttranslational Downregulation of c-FLIP. Clin Cancer Res. 2018 05 15; 24(10):2452-2463.
Score: 0.030